Skip to main content

Table 1 Group Characteristics and Medications

From: Short term elevation in dietary protein intake does not worsen insulin resistance or lipids in older adults with metabolic syndrome: a randomized-controlled trial

Intervention Recommended Protein Intake Elevated Protein Intake
Pre Post Pre Post
Age, yrs 64.5 ± 3.0 60.2 ± 2.8
Gender, M/F 3/3 2/4
Total body mass, kg 108.5 ± 10.6 108.5 ± 10.5 106.0 ± 6.8 105.3 ± 6.8
Lean body mass, kg 59.0 ± 7.4 57.3 ± 6.0 58.1 ± 4.6 56.4 ± 3.8
Body mass index, kg/m2 37.4 ± 2.6 37.4 ± 2.6 37.6 ± 1.4 37.3 ± 1.4
Body fat (%) 41.3 ± 7.5   41.2 ± 3.4  
Total cholesterol, mg/dl 198.3 ± 43.6   188.7 ± 37.9  
Triglyceride, mg/dl 185.3 ± 60.9   171.2 ± 41.5  
HDL cholesterol, mg/dl 44.2 ± 10.1   41.5 ± 7.1  
Glucose, mg/dl 102.5 ± 23.1   99.2 ± 14.3  
Blood pressure, mm Hg
 Systolic blood pressure 143.0 ± 21.8   145.2 ± 17.2  
 Diastolic blood pressure 85.0 ± 9.5   82.8 ± 5.4  
  Medications (# of subjects)
For hypertension     
 Beta blocker    2  
 ACE inhibitor 1   2  
 Calcium channel blocker 1   1  
 Diuretic 2   5  
For lipid or type 2 diabetes     
 Metformin 1   2  
 Glipizide 1    
 Statin 2   1  
  1. Values are expressed as Mean ± SEM. M/F number of male/female subjects. There were no significance differences in any of variables of group characteristics before and after their respective dietary intervention between groups (for all; p > 0.10)